ATG13 and myalgic encephalomeyelitis/chronic fatigue syndrome: To determine the clinical relevance of pSer258-ATG13 inactivation in ME/CFS subjects, we developed a Serine258P-specific ATG13 antibody that was used in a highly sensitive indirect ELISA.